NITROSOUREAS - MODES OF ACTION AND PERSPECTIVES IN THE USE OF HORMONE RECEPTOR AFFINE CARRIER MOLECULES

被引:16
作者
EISENBRAND, G
BERGER, MR
BRIX, HP
FISCHER, JE
MUHLBAUER, K
NOWROUSIAN, MR
PRZYBILSKI, M
SCHNEIDER, MR
STAHL, W
TANG, W
ZELEZNY, O
ZELLER, WJ
机构
[1] W GERMAN TUMOR CTR,DEPT INTERNAL MED,ESSEN,FED REP GER
[2] UNIV MAINZ,DEPT ORGAN CHEM,D-6500 MAINZ,FED REP GER
[3] UNIV REGENSBURG,DEPT CHEM & PHARM,D-8400 REGENSBURG,FED REP GER
[4] GERMAN CANC RES CTR,INST TOXICOL & CHEMOTHERAPY,D-6900 HEIDELBERG 1,FED REP GER
关键词
D O I
10.3109/02841868909111248
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:203 / 211
页数:9
相关论文
共 46 条
[21]  
KEHRER JP, 1985, CANCER RES, V45, P5707
[22]  
KNIGHT WA, 1977, CANCER RES, V37, P4669
[23]  
LIJINSKY W, 1983, CANCER RES, V43, P214
[24]   SIMILAR CARCINOGENIC EFFECTS IN RATS OF 1-ETHYL-1-NITROSO-3-HYDROXYETHYLUREA AND 1-HYDROXYETHYL-1-NITROSO-3-ETHYLUREA [J].
LIJINSKY, W ;
SINGER, GM ;
KOVATCH, RM .
CARCINOGENESIS, 1985, 6 (04) :641-643
[25]   NITROSOUREA-INDUCED DNA SINGLE-STRAND BREAKS [J].
LOWN, JW ;
MCLAUGHLIN, LW .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (10) :1631-1638
[27]  
LUDLUM DB, 1981, NITROSOUREAS CANCER, P21
[28]  
MCCONNELL WR, 1979, CANCER CHEMOTH PHARM, V2, P221
[29]  
Mirecki DM, 1985, LAB MED, V16, P287
[30]   THE INFLUENCE OF N-7 SUBSTITUENTS ON THE STABILITY OF N-7-ALKYLATED GUANOSINES [J].
MULLER, N ;
EISENBRAND, G .
CHEMICO-BIOLOGICAL INTERACTIONS, 1985, 53 (1-2) :173-181